Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
163
-
Total shares
-
18.5M
-
Shares change
-
-28.8K
-
Total reported value, excl. options
-
$2.76B
-
Value change
-
-$22M
-
Put/Call ratio
-
1.39
-
Number of buys
-
80
-
Number of sells
-
-83
-
Price
-
$149.35
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q4 2015
177 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q4 2015.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
.
Largest 10 shareholders include FMR LLC (3.65M shares), AMERIPRISE FINANCIAL INC (2.86M shares), Capital World Investors (1.57M shares), Carmignac Gestion (1.32M shares), ORBIMED ADVISORS LLC (1.12M shares), VANGUARD GROUP INC (1.09M shares), FIRST TRUST ADVISORS LP (589K shares), BlackRock Fund Advisors (436K shares), BlackRock Institutional Trust Company, N.A. (415K shares), and STATE STREET CORP (409K shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.